Total pancreatectomy for chronic pancreatitis

Area of Science:

• Gastroenterology
• Surgical Oncology
• Endocrinology

Background:

• Chronic pancreatitis (CP) is a debilitating condition characterized by severe abdominal pain and malabsorption.
• Total pancreatectomy (TP) is a radical surgical option for end-stage CP when conservative treatments fail.
• Previous pancreatic or biliary surgery is common in patients undergoing TP.

Purpose of the Study:

• To evaluate the outcomes of total pancreatectomy (TP) for chronic pancreatitis.
• To assess pain relief, complications, and long-term survival after TP.
• To determine the need for pancreatic supplementation and endocrine control post-TP.

Main Methods:

• A retrospective survey of 83 patients who underwent TP for chronic pancreatitis between 1977 and 1986 across six British centers.
• Data collected on patient demographics, indications for surgery, previous operations, operative details, complications, and follow-up outcomes.
• Analysis of short-term (30-day) and long-term mortality, pain status, and need for pancreatic enzyme and insulin therapy.

Main Results:

• Severe pain was the primary indication for TP in 82% of patients requiring regular opiates.
• Four (4.8%) in-hospital deaths occurred, with bleeding being the most common cause.
• At a median follow-up of 1.5 years, 72% of survivors were pain-free, and 11% required only occasional analgesia.
• All survivors required pancreatic supplementation, and 38% experienced difficulties with endocrine control.
• 13% of patients experienced late deaths, primarily attributable to the operation.

Conclusions:

• Total pancreatectomy can provide significant pain relief for patients with end-stage chronic pancreatitis.
• While TP improves pain symptoms, it necessitates lifelong pancreatic enzyme and insulin replacement therapy.
• The procedure carries significant operative risks and long-term mortality, requiring careful patient selection.